Publications
239 results found
Ziaj S, Mitchell C, Roufosse C, et al., 2014, Occult microscopic polyangiitis presenting as pyrexia of unknown origin, BRITISH JOURNAL OF HOSPITAL MEDICINE, Vol: 75, Pages: 172-173, ISSN: 1750-8460
Willicombe M, Roufosse C, Brookes P, et al., 2014, Acute Cellular Rejection: Impact of Donor-Specific Antibodies and C4d, TRANSPLANTATION, Vol: 97, Pages: 433-439, ISSN: 0041-1337
- Author Web Link
- Cite
- Citations: 29
Haas M, Sis B, Racusen LC, et al., 2014, Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions, AMERICAN JOURNAL OF TRANSPLANTATION, Vol: 14, Pages: 272-283, ISSN: 1600-6135
- Author Web Link
- Cite
- Citations: 1060
Santos-Nunez E, Brookes P, Willicombe M, et al., 2013, De novo DQ DSA post renal transplantation: incidence and outcomes, INTERNATIONAL JOURNAL OF IMMUNOGENETICS, Vol: 40, Pages: 403-404, ISSN: 1744-3121
Bravou V, Galliford J, McLean A, et al., 2013, A case of chronic antibody-mediated rejection in the making, CLINICAL NEPHROLOGY, Vol: 80, Pages: 306-309, ISSN: 0301-0430
- Author Web Link
- Cite
- Citations: 2
de Kort H, Roufosse C, Bajema IM, et al., 2013, Pancreas transplantation, antibodies and rejection: where do we stand?, CURRENT OPINION IN ORGAN TRANSPLANTATION, Vol: 18, Pages: 337-344, ISSN: 1087-2418
- Author Web Link
- Cite
- Citations: 16
de Kort H, Willicombe M, Brookes P, et al., 2013, Microcirculation Inflammation Is Superior to Peritubular Capillary Basement Membrane Multilayering for Outcome Prediction in Renal Transplant Patients with De Novo Donor-Specific Antibodies, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 39-40, ISSN: 1600-6135
de Kort H, Charif R, Brookes P, et al., 2013, Microcirculation Injury Associates with Donor-Specific Anti-HLA Antibodies in ABO Incompatible Renal Transplant Patients., 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 333-333, ISSN: 1600-6135
McLean A, Dominy K, De Kort H, et al., 2013, Intra-Graft Expression of Transcripts for Endothelial Activation and NK Cell Markers, Detected by Real-Time qPCR, Is Associated with the Presence of Donor Specific Antibodies, and Identifies Kidney Transplants at Risk of Failure, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 142-142, ISSN: 1600-6135
McLean A, Chan K, Galliford J, et al., 2013, 1-Year Outcomes of a Prospective, Open Label, Randomized, Controlled Trial of Standard vs Extended-Release Tacrolimus as Maintenance Monotherapy in Kidney Transplantation after Alemtuzumab Induction with Rapid Steroid Withdrawal (TAESR Trial)., 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 358-358, ISSN: 1600-6135
Willicombe M, Roufosse C, Brookes P, et al., 2013, CD68 Positive Glomerulitis Predicts the Development of Transplant Glomerulopathy in Patients with Cellular Rejection, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 43-44, ISSN: 1600-6135
Willicombe M, Roufosse C, Brookes P, et al., 2013, Potential Importance of 3 Year Surveillance Biopsies in Renal Transplantation, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 41-42, ISSN: 1600-6135
Lawrence C, Willicombe M, Brookes P, et al., 2013, Complement-Activating DSA: Which Assay in Which Setting?, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 141-141, ISSN: 1600-6135
Lawrence C, Willicombe M, Brookes P, et al., 2013, Complement-Activating Low-Level Preformed Donor-Specific Antibodies Detected by C1qScreen™ Predict Early Antibody-Mediated Rejection in Renal Allografts, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 140-141, ISSN: 1600-6135
Charif R, De Kort H, Roufosse C, et al., 2013, Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation?, 13th American Transplant Congress (ATC), Publisher: WILEY-BLACKWELL, Pages: 283-283, ISSN: 1600-6135
- Author Web Link
- Cite
- Citations: 1
de Kort H, Willicombe M, Brookes P, et al., 2013, Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor-Specific Antibodies, AMERICAN JOURNAL OF TRANSPLANTATION, Vol: 13, Pages: 485-492, ISSN: 1600-6135
- Author Web Link
- Cite
- Citations: 85
Lawrence C, Willicombe M, Brookes PA, et al., 2013, Preformed Complement-Activating Low-Level Donor-Specific Antibody Predicts Early Antibody-Mediated Rejection in Renal Allografts, TRANSPLANTATION, Vol: 95, Pages: 341-346, ISSN: 0041-1337
- Author Web Link
- Cite
- Citations: 47
Roufosse CA, Shore I, Moss J, et al., 2012, Peritubular Capillary Basement Membrane Multilayering on Electron Microscopy: A Useful Marker of Early Chronic Antibody-Mediated Damage, TRANSPLANTATION, Vol: 94, Pages: 269-274, ISSN: 0041-1337
- Author Web Link
- Cite
- Citations: 20
Wang Y, Arlt VM, Roufosse CA, et al., 2012, ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues, ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, Vol: 53, Pages: 495-504, ISSN: 0893-6692
- Author Web Link
- Cite
- Citations: 18
Willicombe M, Brookes P, Sergeant R, et al., 2012, De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy, TRANSPLANTATION, Vol: 94, Pages: 172-177, ISSN: 0041-1337
- Author Web Link
- Cite
- Citations: 189
Lawrence C, Willcombe M, Patel M, et al., 2012, Recipient Complotype Does Not Predict Rejection in Renal Transplant Recipients, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 312-312, ISSN: 1600-6135
Chan K, Charif R, Galliford J, et al., 2012, Induction with Alemtuzumab Should Be Weight Adjusted To Achieve Optimal Outcomes in Renal Transplant Recipients., American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 314-314, ISSN: 1600-6135
Willicombe M, Brookes P, Galliford J, et al., 2012, Surveillance Biopsies with Donor Specific Antibody Screening Predict Rejection in Patients Receiving Minimalist Immunosuppressive Regimes, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 80-80, ISSN: 1600-6135
McGuinness DM, Willicombe M, McLean AG, et al., 2012, Recurrent IgA Nephropathy in Renal Transplant Patients Receiving a Steroid Sparing Immunosuppression Regime, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 378-378, ISSN: 1600-6135
Montero R, Chan K, Brookes P, et al., 2012, Reversal of Acute Cellular Rejection in Renal Transplantation Can Be Achieved with a Single Dose of Campath, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 325-326, ISSN: 1600-6135
Lawrence C, Willicombe M, Brookes P, et al., 2012, Complement (C1q)-Fixing De Novo Donor-Specific Antibodies Predict Renal Allograft Loss, Antibody Mediated Rejection and Transplant Glomerulopathy, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 183-183, ISSN: 1600-6135
Lawrence C, Willicombe M, Brookes P, et al., 2012, A Composite Risk Score Is Highly Specific for Predicting Outcomes in Renal Transplant Recipients with De Novo Donor-Specific Antibody., American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 364-365, ISSN: 1600-6135
Galliford J, Chan K, Charif R, et al., 2012, Eculizumab Prevents Allograft Loss from Acute Antibody Mediated Rejection in the Short and Medium Term, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 83-83, ISSN: 1600-6135
- Author Web Link
- Cite
- Citations: 2
Willicombe M, Santos E, Brookes P, et al., 2012, HLA Cw Donor Specific Antibodies Are Associated with Antibody-Mediated Rejection in Renal Transplantation, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 415-415, ISSN: 1600-6135
Shiu KY, Rebollo-Mesa I, Cook T, et al., 2012, Chronic Antibody-Mediated Rejection: B-Cell Dependent Alloreactive IFNγ-Producing CD4+ T Cells Could Be Used as a Biomarker To Determine Responsiveness to Therapy, American Transplant Congress, Publisher: WILEY-BLACKWELL, Pages: 410-410, ISSN: 1600-6135
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.